{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:07:08Z","timestamp":1770322028444,"version":"3.49.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study aimed to assess the clinical efficacy of neurointerventional therapy plus intravenous thrombolysis in patients with acute ischemic stroke (AIS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a single-center retrospective analysis involving 120 AIS patients admitted to our hospital from January 2023 to December 2024. Based on their treatment plans, patients were categorized into an alteplase group (\n                      <jats:italic>n<\/jats:italic>\n                      = 55) and a combination group (\n                      <jats:italic>n<\/jats:italic>\n                      = 65). In both groups, all patients received standard intravenous thrombolysis with alteplase; in the combination group, this was followed by adjunct neurointerventional therapy, including intra-arterial urokinase infusion and, when indicated, mechanical thrombectomy. We compared neurological function scores, inflammatory factor levels, oxidative stress markers, immune function indicators, hemodynamic parameters, quality of life scores, and the total incidence of adverse reactions between the two groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After 3 months of treatment, the combination group demonstrated significantly lower NIHSS and mRS scores, as well as reduced levels of IL-6, TNF-\u03b1, and hs-CRP, compared to the alteplase group (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). Additionally, the combination group exhibited higher SOD levels, lower MDA levels, elevated CD4\n                      <jats:sup>+<\/jats:sup>\n                      counts and CD4\n                      <jats:sup>+<\/jats:sup>\n                      \/CD8\n                      <jats:sup>+<\/jats:sup>\n                      ratios, and decreased CD8\n                      <jats:sup>+<\/jats:sup>\n                      levels (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). Hemodynamically, the combination group had higher minimum cerebral blood flow volume and velocity, along with lower peripheral resistance in cerebral vessels (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). Furthermore, the combination group achieved higher GQOLI-74 scores, indicating improved quality of life (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). Notably, there was no significant difference in the total incidence of adverse reactions between the two groups (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Neurointerventional therapy plus intravenous thrombolysis can improve the neurological function, reduce inflammation and oxidative stress, enhance immune function, improve hemodynamic indicators, improve the quality of life and has good safety in the treatment of patients with AIS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1721322","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:46:07Z","timestamp":1770273967000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impacts of neurointerventional therapy combined with intravenous thrombolysis on neurological function, oxidative stress, and immune function in patients with acute ischemic stroke"],"prefix":"10.3389","volume":"13","author":[{"given":"Yun","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Huai\u2019an Hospital Affiliated to Yangzhou University (The Fifth People\u2019s Hospital of Huai\u2019an), Huai\u2019an","place":["Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huai\u2019an Hospital Affiliated to Yangzhou University (The Fifth People\u2019s Hospital of Huai\u2019an), Huai\u2019an","place":["Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huai\u2019an Hospital Affiliated to Yangzhou University (The Fifth People\u2019s Hospital of Huai\u2019an), Huai\u2019an","place":["Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.2022.1420","article-title":"What is acute ischemic stroke?","volume":"327","author":"Walter","year":"2022","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-med-050823-094312","article-title":"Contemporary management of acute ischemic stroke.","volume":"76","author":"Ho","year":"2025","journal-title":"Annu Rev Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/CCM.0000000000004597","article-title":"Management of acute ischemic stroke.","volume":"48","author":"Herpich","year":"2020","journal-title":"Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1003910","DOI":"10.1371\/journal.pmed.1003910","article-title":"Association of ischemic stroke onset time with presenting severity, acute progression, and long-term outcome: a cohort study.","volume":"19","author":"Ryu","year":"2022","journal-title":"PLoS Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jama.2022.1645","article-title":"Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial.","volume":"327","author":"Ren\u00fa","year":"2022","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"15625","DOI":"10.3390\/ijms232415625","article-title":"Increased oxidative stress markers in acute ischemic stroke patients treated with thrombolytics.","volume":"23","author":"Pawluk","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1608353","DOI":"10.3389\/fimmu.2025.1608353","article-title":"The role of inflammation in ischemic stroke: from biomarker to treatment.","volume":"16","author":"Xiao","year":"2025","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"911661","DOI":"10.3389\/fimmu.2022.911661","article-title":"Systemic immune responses after ischemic stroke: from the center to the periphery.","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1628717","DOI":"10.3389\/fneur.2025.1628717","article-title":"Assessment of cerebral hemodynamic changes in acute ischemic stroke patients following mechanical thrombectomy using CT perfusion imaging.","volume":"16","author":"Tian","year":"2025","journal-title":"Front Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e076161","DOI":"10.1136\/bmj-2023-076161","article-title":"Advances in treatments for acute ischemic stroke.","volume":"389","author":"Sharma","year":"2025","journal-title":"BMJ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/ana.27007","article-title":"Golden hour intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analysis.","volume":"96","author":"Al-Ajlan","year":"2024","journal-title":"Ann Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/S0140-6736(23)02032-9","article-title":"Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial.","volume":"402","author":"Bendszus","year":"2023","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJMoa2213379","article-title":"Trial of endovascular therapy for acute ischemic stroke with large infarct.","volume":"388","author":"Huo","year":"2023","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/jth.15336","article-title":"Thrombolytic strategies for ischemic stroke in the thrombectomy era.","volume":"19","author":"Gauberti","year":"2021","journal-title":"J Thromb Haemost."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.1038\/s41598-023-35532-7","article-title":"Mechanical thrombectomy combined with intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analyses.","volume":"13","author":"Zheng","year":"2023","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0140-6736(22)00537-2","article-title":"Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.","volume":"400","author":"Fischer","year":"2022","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0140-6736(22)00564-5","article-title":"Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4\u22c55 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial.","volume":"400","author":"Mitchell","year":"2022","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/15910199231154331","article-title":"Mechanical thrombectomy alone versus with thrombolysis for ischemic stroke: a meta-analysis of randomized trials.","volume":"3","author":"Kobeissi","year":"2023","journal-title":"Interv Neuroradiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"18757","DOI":"10.1038\/s41598-025-03249-4","article-title":"Comparison of thrombectomy alone versus bridging thrombolysis in a US population using regression discontinuity analysis.","volume":"15","author":"Kim","year":"2025","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0140-6736(22)01054-6","article-title":"Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.","volume":"400","author":"Menon","year":"2022","journal-title":"Lancet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S0140-6736(25)00194-1","article-title":"Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.","volume":"405","author":"Hill","year":"2025","journal-title":"Lancet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1161\/STROKEAHA.121.034480","article-title":"Standardized nomenclature for modified rankin scale global disability outcomes: consensus recommendations from stroke therapy academic industry roundtable XI.","volume":"52","author":"Saver","year":"2021","journal-title":"Stroke."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1161\/STROKEAHA.121.034859","article-title":"National institutes of health stroke scale as an outcome in stroke research: value of ANCOVA over analyzing change from baseline.","volume":"53","author":"Mistry","year":"2022","journal-title":"Stroke."},{"key":"B25","first-page":"1159","article-title":"Effects of comfort nursing on pain and quality of life in children undergoing tonsillectomy.","volume":"15","author":"Jiang","year":"2023","journal-title":"Am J Transl Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1056\/NEJMoa2413344","article-title":"Alteplase for posterior circulation ischemic stroke at 4.5 to 24 Hours.","volume":"392","author":"Yan","year":"2025","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2024.0589","article-title":"Time to treatment with intravenous thrombolysis before thrombectomy and functional outcomes in acute ischemic stroke: a meta-analysis.","volume":"331","author":"Kaesmacher","year":"2024","journal-title":"JAMA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/STROKEAHA.124.048536","article-title":"Thrombolysis for ischemic stroke beyond the 4.5-hour window: a meta-analysis of randomized clinical trials.","volume":"56","author":"G\u00fcnkan","year":"2025","journal-title":"Stroke."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e031669","DOI":"10.1161\/JAHA.123.031669","article-title":"Intravenous thrombolysis for acute ischemic stroke in patients with recent direct oral anticoagulant use: a systematic review and meta-analysis.","volume":"12","author":"Ghannam","year":"2023","journal-title":"J Am Heart Assoc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/ptr.7843","article-title":"Effects of intravenous thrombolysis with and without salvianolic acids for injection on the functional recovery of patients with acute ischemic stroke: a systematic review, meta-analysis, and trial sequential analysis.","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1161\/CIRCRESAHA.121.319948","article-title":"Advances in acute ischemic stroke therapy.","volume":"130","author":"Xiong","year":"2022","journal-title":"Circ Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3892\/etm.2020.9404","article-title":"Efficacy of neurointervention combined with intravenous thrombolysis in the treatment of ischemic cerebrovascular disease and its influence on neurological function and prognosis of patients.","volume":"20","author":"Li","year":"2020","journal-title":"Exp Ther Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00281-022-00943-7","article-title":"Inflammatory responses after ischemic stroke.","volume":"44","author":"DeLong","year":"2022","journal-title":"Semin Immunopathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"828447","DOI":"10.3389\/fimmu.2022.828447","article-title":"Interleukins and Ischemic Stroke.","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"10614","DOI":"10.3390\/ijms231810614","article-title":"Selected mediators of inflammation in patients with acute ischemic stroke.","volume":"23","author":"Pawluk","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e030007","DOI":"10.1161\/JAHA.123.030007","article-title":"HS-CRP modifies the prognostic value of platelet count for clinical outcomes after ischemic stroke.","volume":"12","author":"Liu","year":"2023","journal-title":"J Am Heart Assoc."},{"key":"B37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","article-title":"Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions.","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Target Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2101526","DOI":"10.1002\/advs.202101526","article-title":"Macrophage-Disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke.","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"155817","DOI":"10.1016\/j.phymed.2024.155817","article-title":"B. glomerulata promotes neuroprotection against ischemic stroke by inhibiting apoptosis through the activation of PI3K\/AKT\/mTOR pathway.","volume":"132","author":"Xu","year":"2024","journal-title":"Phytomedicine."},{"key":"B40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-024-02095-6","article-title":"Redox regulation: mechanisms, biology and therapeutic targets in diseases.","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fimmu.2020.00294","article-title":"Glial cells: role of the immune response in ischemic stroke.","volume":"11","author":"Xu","year":"2020","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1287857","DOI":"10.3389\/fimmu.2023.1287857","article-title":"Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural compounds.","volume":"14","author":"Gong","year":"2023","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke. the PROACT II study: a randomized controlled trial. prolyse in acute cerebral thromboembolism.","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA."},{"key":"B44","first-page":"1470","article-title":"Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.","volume":"25","author":"Lee","year":"2004","journal-title":"AJNR Am J Neuroradiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"861913","DOI":"10.3389\/fcvm.2022.861913","article-title":"Clinical imaging of the penumbra in ischemic stroke: from the concept to the era of mechanical thrombectomy.","volume":"9","author":"Chalet","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/svn-2022-001547","article-title":"Endovascular thrombectomy with or without intravenous alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials.","volume":"7","author":"Wang","year":"2022","journal-title":"Stroke Vascular Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/life13010185","article-title":"Direct mechanical thrombectomy versus prior bridging intravenous thrombolysis in acute ischemic stroke: a systematic review and meta-analysis.","volume":"13","author":"Kolahchi","year":"2023","journal-title":"Life."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e001847","DOI":"10.1111\/ene.70270","article-title":"Intra-Arterial thrombolysis after successful thrombectomy: a systematic review and meta-analysis of randomized controlled trials.","volume":"5","author":"Xu","year":"2025","journal-title":"Stroke: Vascular Intervent Neurol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1721322\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:46:08Z","timestamp":1770273968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1721322\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":48,"alternative-id":["10.3389\/fmed.2026.1721322"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1721322","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"article-number":"1721322"}}